| scholarly article | Q13442814 |
| P50 | author | Jose C Clemente | Q87191879 |
| Julia Manasson | Q56547249 | ||
| P2093 | author name string | Jose U Scher | |
| P2860 | cites work | Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis | Q21128781 |
| Microbial view of central nervous system autoimmunity | Q22252213 | ||
| Probiotics for induction of remission in ulcerative colitis | Q24242963 | ||
| Probiotics for maintenance of remission in Crohn's disease | Q24244110 | ||
| Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. | Q24521497 | ||
| Association between coeliac disease and psoriasis: Italian primary care multicentre study | Q86693606 | ||
| Seres's pioneering microbiome drug fails mid-stage trial | Q88529589 | ||
| Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice | Q24523182 | ||
| Diversity of the human intestinal microbial flora | Q24544241 | ||
| Human gut microbiome viewed across age and geography | Q24602950 | ||
| Linking long-term dietary patterns with gut microbial enterotypes | Q24609914 | ||
| 16S ribosomal DNA amplification for phylogenetic study | Q24681548 | ||
| Microbial diversity in the deep sea and the underexplored "rare biosphere" | Q24685531 | ||
| Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study | Q24685821 | ||
| Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis | Q24798563 | ||
| Lactobacillus GG in inducing and maintaining remission of Crohn's disease | Q24806098 | ||
| Fat intake and composition of fatty acids in serum phospholipids in a randomized, controlled, Mediterranean dietary intervention study on patients with rheumatoid arthritis | Q24811536 | ||
| The Gut Microbiota in Immune-Mediated Inflammatory Diseases | Q26741414 | ||
| Metagenomics, Metatranscriptomics, and Metabolomics Approaches for Microbiome Analysis | Q26747593 | ||
| Diet and psoriasis, part II: celiac disease and role of a gluten-free diet | Q26999037 | ||
| Fiber and prebiotics: mechanisms and health benefits | Q27014809 | ||
| Diet and psoriasis, part III: role of nutritional supplements | Q27023752 | ||
| HLA-B27 and human β2-microglobulin affect the gut microbiota of transgenic rats | Q27313830 | ||
| How colonization by microbiota in early life shapes the immune system | Q28069301 | ||
| Microbiome, Metabolome and Inflammatory Bowel Disease | Q28078126 | ||
| Treatment of ulcerative colitis using fecal bacteriotherapy | Q28179819 | ||
| Duodenal infusion of donor feces for recurrent Clostridium difficile | Q28283517 | ||
| Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment | Q28710518 | ||
| Diet rapidly and reproducibly alters the human gut microbiome | Q29547454 | ||
| Community structure and metabolism through reconstruction of microbial genomes from the environment | Q29547528 | ||
| The human microbiome project | Q29547661 | ||
| The gut microbiota shapes intestinal immune responses during health and disease | Q29547727 | ||
| Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients | Q29614261 | ||
| A microbial symbiosis factor prevents intestinal inflammatory disease | Q29614263 | ||
| Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells | Q29614271 | ||
| Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans | Q29614455 | ||
| The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis | Q29616351 | ||
| Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome | Q29616853 | ||
| Inflammatory mechanisms in obesity | Q29617932 | ||
| Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells | Q29618126 | ||
| Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota | Q29618128 | ||
| Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis | Q29619978 | ||
| Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation | Q29620116 | ||
| Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis | Q31125499 | ||
| Diagnosis of multiple sclerosis: progress and challenges | Q31144846 | ||
| A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice | Q36403371 | ||
| A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. | Q36516482 | ||
| Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells. | Q36614277 | ||
| Obesity and the risk of psoriatic arthritis: a population-based study. | Q36820863 | ||
| Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor | Q36984429 | ||
| Probiotics and remission of ulcerative colitis: a systematic review | Q37031840 | ||
| NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora | Q37061082 | ||
| Resolution of severe Clostridium difficile infection following sequential fecal microbiota transplantation | Q37075702 | ||
| Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut | Q37097658 | ||
| Role of the Gut Microbiome in Modulating Arthritis Progression in Mice | Q37145101 | ||
| Prebiotics in chronic intestinal inflammation | Q37285115 | ||
| Patient-Specific Bacteroides Genome Variants in Pouchitis | Q37417363 | ||
| Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus | Q37487983 | ||
| Short- and long-term effects of oral vancomycin on the human intestinal microbiota | Q37509525 | ||
| The intestinal microbiota in inflammatory bowel diseases: time to connect with the host | Q37743105 | ||
| The gut microflora and its variety of roles in health and disease | Q38000051 | ||
| The role of omega-3 derived resolvins in arthritis | Q38084001 | ||
| Exclusive enteral nutrition and induction of remission of active Crohn's disease in children | Q38096031 | ||
| Alcohol consumption as a preventive factor for developing rheumatoid arthritis: a dose-response meta-analysis of prospective studies | Q38125156 | ||
| Nutritional therapy in pediatric Crohn disease: the specific carbohydrate diet | Q38139213 | ||
| Remote control-triggering of brain autoimmune disease in the gut. | Q38155702 | ||
| Use of exclusive enteral nutrition in adults with Crohn's disease: a review. | Q38166712 | ||
| The role of adipose tissue immune cells in obesity and low-grade inflammation. | Q38227543 | ||
| Targeting the Microbiome in Inflammatory Bowel Disease: Critical Evaluation of Current Concepts and Moving to New Horizons. | Q38586276 | ||
| Commensal bacteria make GPCR ligands that mimic human signalling molecules | Q38635610 | ||
| Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy | Q38710721 | ||
| Bread Affects Clinical Parameters and Induces Gut Microbiome-Associated Personal Glycemic Responses | Q38737995 | ||
| Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. | Q38755858 | ||
| The microbiome in early life: implications for health outcomes | Q38889058 | ||
| Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial | Q38933717 | ||
| Psoriasis and Risk of Celiac Disease: A Systematic Review and Meta-analysis | Q38952636 | ||
| IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote TH17-dependent inflammation | Q38971098 | ||
| Long-term dietary quality and risk of developing rheumatoid arthritis in women | Q38991161 | ||
| Inflammatory disease caused by intestinal pathobionts | Q39131979 | ||
| Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme | Q73216181 | ||
| Dietary factors in relation to rheumatoid arthritis: a role for olive oil and cooked vegetables? | Q73233172 | ||
| Infectious history | Q73703818 | ||
| Germ-free mice do not develop ankylosing enthesopathy, a spontaneous joint disease | Q73822489 | ||
| Crohn's disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn's disease? | Q74126152 | ||
| The role of microflora in the development of intestinal inflammation: acute and chronic colitis induced by dextran sulfate in germ-free and conventionally reared immunocompetent and immunodeficient mice | Q77775758 | ||
| The role of environmental antigens in the spontaneous development of autoimmunity in MRL-lpr mice | Q77823429 | ||
| Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study | Q79306438 | ||
| High prevalence of celiac disease in psoriasis | Q79323537 | ||
| Effects of butyrate on intestinal barrier function in a Caco-2 cell monolayer model of intestinal barrier | Q79519719 | ||
| Impact of obesity and smoking on psoriasis presentation and management | Q81645553 | ||
| The probiotic preparation, VSL#3 induces remission in patients with mild-to-moderately active ulcerative colitis | Q84290217 | ||
| The link between obesity and psoriatic arthritis | Q84575442 | ||
| Coeliac disease associated with psoriasis | Q84591697 | ||
| Evaluation of body composition parameters in patients with psoriasis | Q85651258 | ||
| Drugging the gut microbiome | Q35573259 | ||
| Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis | Q35594237 | ||
| Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial | Q35598580 | ||
| Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation | Q35634488 | ||
| Protein, iron, and meat consumption and risk for rheumatoid arthritis: a prospective cohort study | Q35769098 | ||
| High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome | Q35791181 | ||
| Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. | Q35816184 | ||
| The microbiome of uncontacted Amerindians | Q35897279 | ||
| A pilot study of a Mediterranean-type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow. | Q35954610 | ||
| Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial | Q36005129 | ||
| The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions | Q36038992 | ||
| Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study | Q36087085 | ||
| Are multi-omics enough? | Q36116377 | ||
| High Sodium Intake Is Associated With Self-Reported Rheumatoid Arthritis: A Cross Sectional and Case Control Analysis Within the SUN Cohort | Q36256039 | ||
| Discovery of Reactive Microbiota-Derived Metabolites that Inhibit Host Proteases | Q36256794 | ||
| High salt reduces the activation of IL-4- and IL-13-stimulated macrophages | Q36266456 | ||
| The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models | Q36289990 | ||
| Metagenomics: DNA sequencing of environmental samples. | Q36320425 | ||
| The germfree state prevents development of gut and joint inflammatory disease in HLA-B27 transgenic rats | Q36364133 | ||
| Exploring mixed microbial community functioning: recent advances in metaproteomics. | Q36379098 | ||
| Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study | Q33296911 | ||
| Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing | Q33385985 | ||
| Dietary fiber and prebiotics and the gastrointestinal microbiota | Q33562095 | ||
| Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers | Q33659058 | ||
| Intraluminal pH of the human gastrointestinal tract. | Q33696903 | ||
| The treatment-naive microbiome in new-onset Crohn's disease | Q33762817 | ||
| Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis | Q33827644 | ||
| Alcohol consumption and risk of incident rheumatoid arthritis in women: a prospective study | Q33976635 | ||
| Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption | Q33983739 | ||
| Characterization of Phascolarctobacterium succinatutens sp. nov., an asaccharolytic, succinate-utilizing bacterium isolated from human feces | Q34073927 | ||
| Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease | Q34240397 | ||
| Obesity and risk of incident psoriatic arthritis in US women | Q34283211 | ||
| Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis | Q34312767 | ||
| Intestinal dysbiosis associated with systemic lupus erythematosus | Q34334692 | ||
| Fish consumption and risk of rheumatoid arthritis: a dose-response meta-analysis | Q34363285 | ||
| A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis | Q34369987 | ||
| Crosstalk between Gut Microbiota and Dietary Lipids Aggravates WAT Inflammation through TLR Signaling | Q34491604 | ||
| Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet | Q34506893 | ||
| Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans | Q34511374 | ||
| Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis | Q34511550 | ||
| A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease | Q34588311 | ||
| Dynamics of gut microbiota in autoimmune lupus | Q34595444 | ||
| An enteric virus can replace the beneficial function of commensal bacteria | Q34641111 | ||
| Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis | Q34719029 | ||
| Altered microbiota associated with abnormal humoral immune responses to commensal organisms in enthesitis-related arthritis | Q34746752 | ||
| Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease | Q34791372 | ||
| Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis | Q35081904 | ||
| The gut microbiota in mouse models of inflammatory bowel disease | Q35117031 | ||
| Strengths and limitations of 16S rRNA gene amplicon sequencing in revealing temporal microbial community dynamics. | Q35142841 | ||
| Mediterranean diet and incidence of rheumatoid arthritis in women | Q35209064 | ||
| Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection. | Q35341537 | ||
| Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent gut microbiota metabolite production. | Q35458175 | ||
| An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis | Q35552423 | ||
| Vitamin C and the risk of developing inflammatory polyarthritis: prospective nested case-control study | Q35554315 | ||
| The gut microbiome and microbial translocation in multiple sclerosis | Q39175175 | ||
| Heterogeneity of response to biologic treatment: perspective for psoriasis | Q39371287 | ||
| Regulation of inflammation by microbiota interactions with the host. | Q39443984 | ||
| Th17 responses and natural IgM antibodies are related to gut microbiota composition in systemic lupus erythematosus patients | Q39865576 | ||
| Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis | Q40227125 | ||
| Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis | Q40974392 | ||
| Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis | Q41235253 | ||
| Prevalence of Obesity in Patients with Psoriasis: Results of the National Study PsoHealth3. | Q41557291 | ||
| Brief Report: Intestinal Dysbiosis in Ankylosing Spondylitis | Q41652119 | ||
| Inflammation-associated adherent-invasive Escherichia coli are enriched in pathways for use of propanediol and iron and M-cell translocation | Q41735801 | ||
| Fish oil in recent onset rheumatoid arthritis: a randomised, double-blind controlled trial within algorithm-based drug use. | Q41924055 | ||
| Interaction between dietary sodium and smoking increases the risk for rheumatoid arthritis: results from a nested case-control study. | Q42681406 | ||
| Dietary fish and fish oil and the risk of rheumatoid arthritis | Q43281056 | ||
| Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity | Q43433033 | ||
| Selective carbohydrate utilization by lactobacilli and bifidobacteria | Q44317857 | ||
| Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis | Q44368185 | ||
| Psoriasis improvement after bariatric surgery | Q44434128 | ||
| Medicines from microbiota | Q44469787 | ||
| Effect of exclusive enteral nutrition on gut microflora function in children with Crohn's disease | Q44474316 | ||
| Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis | Q45166043 | ||
| Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial | Q45249138 | ||
| Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease. | Q45939318 | ||
| Different Amplicon Targets for Sequencing-Based Studies of Fungal Diversity. | Q46348377 | ||
| Intestinal Metabolites Are Profoundly Altered in the Context of HLA-B27 Expression and Functionally Modulate Disease in a Rat Model of Spondyloarthritis | Q46349028 | ||
| A prominent glycyl radical enzyme in human gut microbiomes metabolizes trans-4-hydroxy-l-proline. | Q46420243 | ||
| Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine | Q46470525 | ||
| Fecal Microbiota Transplantation for Ulcerative Colitis: Not Just Yet. | Q46722660 | ||
| Serum cortisol mediates the relationship between fecal Ruminococcus and brain N-acetylaspartate in the young pig. | Q47141429 | ||
| Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. | Q48819558 | ||
| Inulin-type fructans of longer degree of polymerization exert more pronounced in vitro prebiotic effects | Q49063537 | ||
| Diet and rheumatoid arthritis in women: a possible protective effect of fish consumption. | Q51020310 | ||
| Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. | Q51150907 | ||
| TLR Tolerance as a Treatment for Central Nervous System Autoimmunity. | Q51583877 | ||
| The immune response to autologous bacteroides in ankylosing spondylitis is characterized by reduced interleukin 10 production. | Q51812410 | ||
| High dose probiotic and prebiotic cotherapy for remission induction of active Crohn's disease. | Q53231256 | ||
| Disease concomitance in psoriasis. | Q54171239 | ||
| A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. | Q54355738 | ||
| Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. | Q54412643 | ||
| The skinny on psoriasis and obesity. | Q54447146 | ||
| Commensal intestinal bacterial strains trigger ankylosing enthesopathy of the ankle in inbred B10.BR (H-2(k)) male mice. | Q54512985 | ||
| Omega-3 polyunsaturated fatty acids and the treatment of rheumatoid arthritis: a meta-analysis. | Q55056504 | ||
| Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. | Q55058314 | ||
| Dietary extra-virgin olive oil prevents inflammatory response and cartilage matrix degradation in murine collagen-induced arthritis. | Q55067876 | ||
| Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin | Q57241178 | ||
| Protective effects of hydroxytyrosol-supplemented refined olive oil in animal models of acute inflammation and rheumatoid arthritis | Q57983067 | ||
| Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice | Q59069058 | ||
| Probiotic Therapy for the Treatment of Spondyloarthritis: A Randomized Controlled Trial | Q60684076 | ||
| Is Lactobacillus GG Helpful in Children With Crohn’s Disease? Results of a Preliminary, Open-Label Study | Q63285887 | ||
| Comparative study of NZB mice under germfree and conventional conditions | Q67326832 | ||
| HLA-B27 as a relative risk factor in ankylosing enthesopathy in transgenic mice | Q72222906 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microbiome | Q1330402 |
| P304 | page(s) | j5145 | |
| P577 | publication date | 2018-01-08 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | The role of the gut microbiome in systemic inflammatory disease | |
| P478 | volume | 360 |
| Q90121995 | A Double Humanized BLT-mice Model Featuring a Stable Human-Like Gut Microbiome and Human Immune System |
| Q60952852 | A Systematic Review, Meta-Analysis, and Meta-Regression Evaluating the Efficacy and Mechanisms of Action of Probiotics and Synbiotics in the Prevention of Surgical Site Infections and Surgery-Related Complications |
| Q90189684 | An Integrated Multi-Disciplinary Perspectivefor Addressing Challenges of the Human Gut Microbiome |
| Q64921536 | Characterisation of the nasal microbiota in granulomatosis with polyangiitis. |
| Q64228734 | Current Understanding of Gut Microbiota in Mood Disorders: An Update of Human Studies |
| Q64237639 | Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis |
| Q64075735 | Diet and Inflammation in Cognitive Ageing and Alzheimer's Disease |
| Q64228621 | Diet in the Driving Seat: Natural Diet-Immunity-Microbiome Interactions in Wild Fish |
| Q60954896 | Diet, Microbiota, and Gut Permeability-The Unknown Triad in Rheumatoid Arthritis |
| Q64122818 | Dietary raisin intake has limited effect on gut microbiota composition in adult volunteers |
| Q93052272 | Environmental Exposures and Autoimmune Diseases: Contribution of Gut Microbiome |
| Q92072015 | Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate |
| Q58546956 | Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease |
| Q93047396 | Gut Microbiota as a Therapeutic Target to Ameliorate the Biochemical, Neuroanatomical, and Behavioral Effects of Traumatic Brain Injuries |
| Q55518751 | Gut microbial diversity is associated with lower arterial stiffness in women. |
| Q90257844 | Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes |
| Q92397655 | Gut microbiota alterations associated with reduced bone mineral density in older adults |
| Q48043102 | Human Microbiome Acquisition and Bioinformatic Challenges in Metagenomic Studies |
| Q99234001 | Human genetic determinants of the gut microbiome and their associations with health and disease: a phenome-wide association study |
| Q99551376 | In vitro ecology: a discovery engine for microbiome therapies |
| Q58608841 | Integrative bioinformatics identifies postnatal lead (Pb) exposure disrupts developmental cortical plasticity |
| Q100731060 | Intestinal microbiology shapes population health impacts of diet and lifestyle risk exposures in Torres Strait Islander communities |
| Q93147108 | Meta-taxonomic analysis of prokaryotic and eukaryotic gut flora in stool samples from visceral leishmaniasis cases and endemic controls in Bihar State India |
| Q91933893 | Minor compositional alterations in faecal microbiota after five weeks and five months storage at room temperature on filter papers |
| Q92135848 | New Therapeutic Targets in Autoimmune Cholangiopathies |
| Q58560851 | Orally administered gold nanoparticles protect against colitis by attenuating Toll-like receptor 4- and reactive oxygen/nitrogen species-mediated inflammatory responses but could induce gut dysbiosis in mice |
| Q90258526 | Physical Activity, Immune System, and the Microbiome in Cardiovascular Disease |
| Q89965206 | Potential Elimination of Human Gut Resistome by Exploiting the Benefits of Functional Foods |
| Q90331718 | Seven facts and five initiatives for gut microbiome research |
| Q92012266 | The Microbiota and Cancer Cachexia |
| Q89660471 | The Vaginal Microbiome as a Tool to Predict rASRM Stage of Disease in Endometriosis: a Pilot Study |
| Q90180433 | The developing gut-lung axis: postnatal growth restriction, intestinal dysbiosis, and pulmonary hypertension in a rodent model |
| Q90093282 | The greater inflammatory pathway-high clinical potential by innovative predictive, preventive, and personalized medical approach |
| Q64073396 | The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis |
| Q92759825 | The path toward using microbial metabolites as therapies |
| Q90737847 | Therapeutic potential of aryl hydrocarbon receptor in autoimmunity |
Search more.